MEDPACE HOLDINGS INC (MEDP)
US58506Q1094 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to MEDP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 456.09. This target is 15.78% above the current price.
MEDP was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about MEDP.
In the previous month the buy percentage consensus was at a similar level.
MEDP was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-29 | TD Cowen | Initiate | Buy |
| 2024-05-28 | Mizuho | Initiate | Buy |
| 2024-04-24 | Guggenheim | Maintains | Buy -> Buy |
| 2024-04-24 | Baird | Maintains | Outperform -> Outperform |
| 2024-04-23 | Jefferies | Upgrade | Hold -> Buy |
| 2024-03-18 | Deutsche Bank | Initiate | Hold |
| 2024-03-08 | UBS | Maintains | Buy -> Buy |
| 2024-02-15 | UBS | Upgrade | Neutral -> Buy |
| 2024-02-14 | Baird | Maintains | Outperform -> Outperform |
| 2024-01-17 | Baird | Maintains | Outperform -> Outperform |
| 2023-10-24 | Baird | Upgrade | Neutral -> Outperform |
| 2023-07-25 | Guggenheim | Maintains | Buy -> Buy |
| 2023-05-08 | Guggenheim | Upgrade | Neutral -> Buy |
| 2023-02-15 | Baird | Maintains | Neutral |
| 2022-10-27 | UBS | Upgrade | Sell -> Neutral |
| 2022-10-26 | Baird | Maintains | Neutral |
| 2022-09-07 | UBS | Initiate | Sell |
| 2022-05-24 | Guggenheim | Initiate | Neutral |
| 2021-07-20 | Credit Suisse | Maintains | Outperform |
| 2021-03-17 | Credit Suisse | Maintains | Outperform |
| 2021-02-17 | Truist Securities | Maintains | Buy |
| 2021-02-16 | Credit Suisse | Maintains | Outperform |